Hertle L, Nawrath H
J Urol. 1984 Dec;132(6):1270-4. doi: 10.1016/s0022-5347(17)50121-4.
The effects of the calcium channel blockers verapamil and nifedipine on norepinephrine-induced activation were studied in different tissues of the human upper urinary tract. In usually inactive ureteral muscle strips, norepinephrine induced predominantly phasic contractions with only minimal effects on resting tension. In contrast, in isolated segments of the renal calyx and pelvis, irrespective of preexisting spontaneous phasic activity, the same agonist effected a long-lasting tonic contraction. These different types of mechanical activity induced by norepinephrine showed different sensitivities to calcium channel blockers, phasic contractions being potently suppressed while the tonic response was little affected by the drugs. This different pattern of response to norepinephrine and the different sensitivity of the responses to calcium channel blockers suggest different and separate coupling mechanisms between the receptors involved and the calcium pools responsible for initiation of contraction. The existence of different calcium pathways activating the contractile proteins in the human upper urinary tract is postulated.
研究了钙通道阻滞剂维拉帕米和硝苯地平对人上尿路不同组织中去甲肾上腺素诱导的激活作用。在通常无活性的输尿管肌条中,去甲肾上腺素主要诱导相位性收缩,对静息张力影响极小。相反,在肾盏和肾盂的分离节段中,无论先前存在的自发相位性活动如何,相同的激动剂都会引起持久的强直性收缩。去甲肾上腺素诱导的这些不同类型的机械活动对钙通道阻滞剂表现出不同的敏感性,相位性收缩被有效抑制,而强直性反应几乎不受药物影响。对去甲肾上腺素的这种不同反应模式以及对钙通道阻滞剂反应的不同敏感性表明,所涉及的受体与负责启动收缩的钙库之间存在不同且独立的偶联机制。推测在人上尿路中存在不同的钙途径激活收缩蛋白。